Effect of anticoagulant therapy on cell-derived microparticles and pregnancy outcome in women with pregnancy loss.
Department of Haemostasis and Thrombosis, National Institute of Immunohaematology (ICMR), KEM Hospital, Mumbai, India.
Rucha
R
Patil
Department of Haemostasis and Thrombosis, National Institute of Immunohaematology (ICMR), KEM Hospital, Mumbai, India.
Kanjaksha
K
Ghosh
Obstetrics and Gynaecology, Nowrosjee Wadia Maternity Hospital, Mumbai, India.
Kaizad
K
Damania
Obstetrics and Gynaecology, Nowrosjee Wadia Maternity Hospital, Mumbai, India.
Vandana
V
Bansal
Obstetrics and Gynaecology, Nowrosjee Wadia Maternity Hospital, Mumbai, India.
Purnima
P
Satoskar
Obstetrics and Gynaecology, Nowrosjee Wadia Maternity Hospital, Mumbai, India.
Anjali
A
Darekar
Department of Haemostasis and Thrombosis, National Institute of Immunohaematology (ICMR), KEM Hospital, Mumbai, India. shrimatishetty@yahoo.com.
Shrimati
S
Shetty
D000026:Abortion, Habitual / Q000209:etiology*; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D016022:Case-Control Studies; D055252:Cell-Derived Microparticles / Q000378:metabolism*; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy; D011256:Pregnancy Outcome; D019851:Thrombophilia / Q000188:drug therapy; D055815:Young Adult
D000925:Anticoagulants; D006493:Heparin; D001241:Aspirin
anticoagulant therapy; cell-derived microparticles; heparin; recurrent pregnancy loss; thrombosis